Taiwan · Delayed Price · Currency is TWD HanchorBio Statistics
Total Valuation
HanchorBio has a market cap or net worth of TWD 22.07 billion. The enterprise value is 21.51 billion.
| Market Cap | 22.07B |
| Enterprise Value | 21.51B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HanchorBio has 130.21 million shares outstanding. The number of shares has increased by 52.61% in one year.
| Current Share Class | 130.21M |
| Shares Outstanding | 130.21M |
| Shares Change (YoY) | +52.61% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 70.69 |
| PB Ratio | 37.98 |
| P/TBV Ratio | 51.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 68.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.29 |
| Quick Ratio | 2.13 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.22 |
| Interest Coverage | -190.84 |
Financial Efficiency
Return on equity (ROE) is -154.58% and return on invested capital (ROIC) is -77.27%.
| Return on Equity (ROE) | -154.58% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -77.27% |
| Return on Capital Employed (ROCE) | -101.91% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.46M |
| Profits Per Employee | -4.04M |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HanchorBio has paid 32.07 million in taxes.
| Income Tax | 32.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +161.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +161.08% |
| 50-Day Moving Average | 154.37 |
| 200-Day Moving Average | 118.11 |
| Relative Strength Index (RSI) | 53.72 |
| Average Volume (20 Days) | 613,610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HanchorBio had revenue of TWD 312.22 million and -512.93 million in losses. Loss per share was -4.10.
| Revenue | 312.22M |
| Gross Profit | 312.22M |
| Operating Income | -592.16M |
| Pretax Income | -595.66M |
| Net Income | -512.93M |
| EBITDA | -567.37M |
| EBIT | -592.16M |
| Loss Per Share | -4.10 |
Balance Sheet
The company has 816.01 million in cash and 99.51 million in debt, with a net cash position of 716.51 million or 5.50 per share.
| Cash & Cash Equivalents | 816.01M |
| Total Debt | 99.51M |
| Net Cash | 716.51M |
| Net Cash Per Share | 5.50 |
| Equity (Book Value) | 581.04M |
| Book Value Per Share | 3.29 |
| Working Capital | 496.77M |
Cash Flow
In the last 12 months, operating cash flow was -437.71 million and capital expenditures -18.25 million, giving a free cash flow of -455.96 million.
| Operating Cash Flow | -437.71M |
| Capital Expenditures | -18.25M |
| Depreciation & Amortization | 24.80M |
| Net Borrowing | 35.61M |
| Free Cash Flow | -455.96M |
| FCF Per Share | -3.50 |
Margins
Gross margin is 100.00%, with operating and profit margins of -189.66% and -164.28%.
| Gross Margin | 100.00% |
| Operating Margin | -189.66% |
| Pretax Margin | -190.78% |
| Profit Margin | -164.28% |
| EBITDA Margin | -181.72% |
| EBIT Margin | -189.66% |
| FCF Margin | n/a |
Dividends & Yields
HanchorBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.61% |
| Shareholder Yield | -52.61% |
| Earnings Yield | -2.32% |
| FCF Yield | -2.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HanchorBio has an Altman Z-Score of 11.99 and a Piotroski F-Score of 1.
| Altman Z-Score | 11.99 |
| Piotroski F-Score | 1 |